| DEVOS, D., J. LABREUCHE, O. RASCOL, J.-C. CORVOL, A. DUHAMEL, P. Guyon DELANNOY, W. POEWE, Y. COMPTA, N. PAVESE, E. RŮŽIČKA, P. DUŠEK, B. POST a at. ALL. Trial of Deferiprone in Parkinson’s Disease. The New England Journal of medicine. USA: Massachusetts Medical Society, 2022, roč. 387, NA, s. 2045-2055. ISSN 1533-4406. Dostupné z: https://dx.doi.org/10.1056/NEJMoa2209254. |
Další formáty:
BibTeX
LaTeX
RIS
@article{2243480,
author = {Devos, D. and Labreuche, J. and Rascol, O. and Corvol, J.andC. and Duhamel, A. and Delannoy, P. Guyon and Poewe, W. and Compta, Y. and Pavese, N. and Růžička, E. and Dušek, P. and Post, B. and all, at.},
article_location = {USA},
article_number = {NA},
doi = {http://dx.doi.org/10.1056/NEJMoa2209254},
keywords = {Parkinson’s Disease; neurodegenerative disorder; FAIRPAK II; clinical trial;},
language = {eng},
issn = {1533-4406},
journal = {The New England Journal of medicine},
title = {Trial of Deferiprone in Parkinson’s Disease},
url = {https://www.nejm.org/doi/full/10.1056/NEJMoa2209254},
volume = {387},
year = {2022}
}
TY - JOUR
ID - 2243480
AU - Devos, D. - Labreuche, J. - Rascol, O. - Corvol, J.-C. - Duhamel, A. - Delannoy, P. Guyon - Poewe, W. - Compta, Y. - Pavese, N. - Růžička, E. - Dušek, P. - Post, B. - all, at.
PY - 2022
TI - Trial of Deferiprone in Parkinson’s Disease
JF - The New England Journal of medicine
VL - 387
IS - NA
SP - 2045-2055
EP - 2045-2055
PB - Massachusetts Medical Society
SN - 15334406
KW - Parkinson’s Disease
KW - neurodegenerative disorder
KW - FAIRPAK II
KW - clinical trial;
UR - https://www.nejm.org/doi/full/10.1056/NEJMoa2209254
N2 - BACKGROUND Iron content is increased in the substantia nigra of persons with Parkinson’s disease and may contribute to the pathophysiology of the disorder. Early research suggests that the iron chelator deferiprone can reduce nigrostriatal iron content in persons with Parkinson’s disease, but its effects on disease progression are unclear.
ER -
DEVOS, D., J. LABREUCHE, O. RASCOL, J.-C. CORVOL, A. DUHAMEL, P. Guyon DELANNOY, W. POEWE, Y. COMPTA, N. PAVESE, E. RŮŽIČKA, P. DUŠEK, B. POST a at. ALL. Trial of Deferiprone in Parkinson’s Disease. \textit{The New England Journal of medicine}. USA: Massachusetts Medical Society, 2022, roč.~387, NA, s.~2045-2055. ISSN~1533-4406. Dostupné z: https://dx.doi.org/10.1056/NEJMoa2209254.
|
